AM-411

N/A

Report date: 2024/12/05 14:21:33
NME

Base Information

Drug NameAM-411
Drug Alias NameAM-411
ClassificationSmall molecules
Mechanisms of ActionTranscription factor p65 inhibitors
TargetsTranscription factor p65
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltamira Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A